Skip to main content

Table 2 Cost-effectiveness, Reference-case

From: Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists

Strategy Mean Costs, $ Mean Effects, QALMs Incremental Costs, $ Incremental Effects, QALMs ICER,
$/QALM gained
Community pharmacist-initiated 72.47
(49.74; 99.61)
0.75137
(0.50954; 0.92395)
Family physician-initiated 141.53
(96.11; 198.26)
0.75142
(0.50910; 0.92384)
69.06
(16.16; 129.67)
0.00005
(−0.00673; 0.00718)
1,381,200
Emergency physician-initiated 368.16
(227.21; 543.26)
0.75146
(0.51983; 0.92400)
Extended dominance
  1. Sequential analysis